0 Commentaires
0 Parts
463 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Advancements in Biologics Revolutionize the Neuromyelitis Optica Treatment MarketExecutive Summary Neuromyelitis Optica Treatment Market Research: Share and Size Intelligence The global neuromyelitis optica treatment market size was valued at USD 297.72 million in 2024 and is projected to reach USD 503.94 million by 2032, with a CAGR of 6.80% during the forecast period of 2025 to 2032. The large scale Neuromyelitis Optica Treatment Market report gives...0 Commentaires 0 Parts 670 Vue 0 Aperçu
-
Alzheimer’s Disease Treatment Market Evolves with Breakthroughs in Biologics, Immunotherapy, and AI DiagnosticsIntroduction The Alzheimer’s Disease Treatment Market has gained global attention due to the rising prevalence of Alzheimer’s, one of the most common forms of dementia. Alzheimer’s disease is a progressive neurological disorder that leads to memory loss, cognitive decline, and impaired daily functioning. With an aging global population, the demand for effective...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Biologics Boom Fuels Expansion in Aseptic Fill Finish Manufacturing MarketThe Fill Finish Manufacturing Market is poised for substantial growth, driven by the expanding biologics sector and technological advancements. The market size is projected to nearly double, rising from approximately US$ 8.71 billion in 2022 to about US$ 17.17 billion by 2030, reflecting a strong Compound Annual Growth Rate (CAGR) of 8.9%. Key...0 Commentaires 0 Parts 534 Vue 0 Aperçu
-
How Innovation in Biologics and Gene Therapy Is Shaping the Future of the Multiple Sclerosis Market?Global Executive Summary Multiple Sclerosis Market: Size, Share, and Forecast CAGR Value The global multiple sclerosis market was valued at USD 28.28 billion in 2024 and is expected to reach USD 37.96 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 3.75%, primarily driven by the anticipated launch of new therapies and advancements in...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Muckle Wells Syndrome Market: Orphan Drug Development, Targeted Biologics and JAK Inhibitors, and Gene Therapy Advancements"Detailed Analysis of Executive Summary Muckle Wells Syndrome Market Size and Share Data Bridge Market Research analyzes that the global muckle wells syndrome market which was USD 12.80 billion in 2022, is likely to reach USD 25.48 billion by 2030, and is expected to undergo a CAGR of 4.1% during the forecast period 2023 to 2030. The Muckle Wells Syndrome report makes available the current...0 Commentaires 0 Parts 637 Vue 0 Aperçu
-
Rising Prevalence of Eye Disorders Drives Innovation in the Global Retinal Biologics Market"Executive Summary Retinal Biologics Market Size and Share Forecast Data Bridge Market Research analyses a growth rate in the retinal biologics market in the forecast period 2023-2030. The expected CAGR of retinal biologics market tends to be around 11.6% in the mentioned forecast period. The market was valued at USD 22.2 billion in 2022 and would grow to USD 53.42 billion by...0 Commentaires 0 Parts 635 Vue 0 Aperçu
-
Harshasharma Harshasharma Ajouter une nouvelle offre d'emploi Autre2025-09-30 04:39:19 - Traduire -Spine Biologics Market: Size, Share, and Future Growth"Regional Overview of Executive Summary Spine Biologics Market by Size and Share CAGR Value The global spine biologics market size was valued at USD 3.30 billion in 2024 and is expected to reach USD 4.52 billion by 2032, at a CAGR of 4.03% during the forecast period A consistent market research report like Spine Biologics Market report extends...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Strategic Assessment of the Middle EAST Biologics Contract Manufacturing Market Competitive LandscapeThe Middle EAST Biologics Contract Manufacturing Market was valued at USD 1.5 billion in 2024 and is projected to reach USD 3.8 billion by 2034, registering a CAGR of 9.5%. This growth trajectory is underpinned by several key factors, including increasing demand for biologics, advancements in biomanufacturing technologies, and a growing emphasis on outsourcing among pharmaceutical companies....0 Commentaires 0 Parts 242 Vue 0 Aperçu
-
Virus Filtration Market: Biologics Safety, Viral Clearance Technology, and Pharmaceutical Manufacturing Applications"Latest Insights on Executive Summary Virus Filtration Market Share and Size The global virus filtration market size was valued at USD 5.70 billion in 2024 and is expected to reach USD 14.09 billion by 2032, at a CAGR of 11.98% during the forecast period This Virus Filtration Market research report proves to be true in serving the purpose of businesses of...0 Commentaires 0 Parts 530 Vue 0 Aperçu
-
How the Ustekinumab Market Is Redefining Biologic Therapies for Autoimmune Diseases?Executive Summary Ustekinumab Market Opportunities by Size and Share CAGR Value The global ustekinumab market size was valued at USD 12.07 billion in 2024 and is expected to reach USD 19.09 billion by 2032, at a CAGR of 5.90% during the forecast period Ustekinumab Market research report is a verified and consistent source of information that puts forth a telescopic view of the...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Lupus Therapeutic Market Trends, Opportunities, and Growth ForecastExecutive Summary Lupus Therapeutic Market Opportunities by Size and Share CAGR Value Global lupus therapeutic market size was valued at USD 3.32 billion in 2024 and is projected to reach USD 6.67 billion by 2032, with a CAGR of 9.10% during the forecast period of 2025 to 2032. An international Lupus Therapeutic Market report lends a hand to identify how the market is going to...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
Plus de résultats